pharmaceutical

Thought Leader Select's Meade Issues Statement on Health Reform

FOR IMMEDIATE RELEASE April 1, 2010 (CHAPEL HILL, NC)—Paul Meade, President of Thought Leader Select, a North Carolina firm dedicated to better engagement and more sophisticated deployment of key opinion leaders for the pharmaceutical industry, issued the following statement regarding the Pharmaceutical Research and Manufacturing Association of America’s (PhRMA) March 21 statement on healthcare reform. …

Thought Leader Select's Meade Issues Statement on Health Reform Read More »

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma, and Patients—Part Five

Over the past several weeks, we’ve talked about how collaborations among key opinion leaders, clinical investigators and pharmaceutical and biotechnology companies benefit the companies, the KOLs or clinical investigators, and patients. The foundation of these mutually-beneficial collaborations is the objective, methodical approach to understanding KOLs’ and clinical investigators’ skills and experiences. Many methods promise to …

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma, and Patients—Part Five Read More »

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma, and Patients—Part Four

Pharmaceutical & Biotechnology Companies Provide Early Knowledge-building Opportunities for KOLs and Clinical Investigators Understanding the value that key opinion leaders provide pharmaceutical and biotechnology companies is clear, but how do companies benefit thought leaders and clinical investigators? By definition, KOLs are physicians, scientists and academics who devote time to studying and advancing their craft. Often, …

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma, and Patients—Part Four Read More »

Thought Leader Select Names Napier to Lead Research Teams

Today’s Press Release from the offices of Thought Leader Select: (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, announces the hiring of Rhonda Napier as research manager. Ms. Napier, a native of Waterford, PA, brings …

Thought Leader Select Names Napier to Lead Research Teams Read More »

Thought Leader Select begins key research and advisory services for seven global pharmaceutical companies

New press release out today, celebrating the tremendous efforts of our business development and research teams. FOR IMMEDIATE RELEASE March 9, 2009 (CHAPEL HILL, NC)  Thought Leader Select, a company dedicated to delivering solutions for better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, announces on-going research …

Thought Leader Select begins key research and advisory services for seven global pharmaceutical companies Read More »

Thought Leader Select Part of a New Wave of Pharma Partners

An interesting article popped up this week in PharmaLive’s Product Marketing Weekly.  Highlighting a new wave of external partners defining Pharma 3.0, the article focused on the effects of downsizing in the industry, and how pharmaceutical companies, now more than ever, are turning to external partners for non-core business functions. At Thought Leader Select, we …

Thought Leader Select Part of a New Wave of Pharma Partners Read More »

The Numbers Don't Lie: The Global Impact of Thought Leader Select

Since 2005, Thought Leader Select has profiled over 4800 key opinion leaders and over 300 centers of excellence in the field of healthcare. The scope of our 72 completed research projects spans four continents—North America, Europe, Africa, and Asia. We have covered thought leaders in 12 therapeutic areas and over 33 disease states for the …

The Numbers Don't Lie: The Global Impact of Thought Leader Select Read More »